(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
23 Most Amusing Messages At any point Sent Among Kids and Their Folks - 2Ski Resorts Universally: A Colder time of year Wonderland Guide
- 3Hilary Duff announces new album ‘Luck… or Something,’ her first in over 10 years: ‘Excited is the largest understatement’
- 437 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- 5Famous Network programs in Europe and America
- 5 Great Youngster Care Administrations To Watch in 2024
- Vote in favor of Your #1 Climbing boots Now
- vote in favor of Your #1 kind of climate
- Fundamental Monetary Guidance for Going into Business
- Vacation destinations in America
- Inside Kathy Hilton’s Christmas pajama party: caviar bumps, champagne vending machines and a mansion full of Housewives
- Starbucks' new 'Bearista' cup is causing a stir — and is being listed on eBay for $600
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- Audits of Espresso Types: Which Brew Is for You?
